Vyvanse Duration: What the Label Says vs What Users Experience

Vyvanse is labeled to last 10 to 14 hours in adults, but most ADHDers feel it working closer to 8 to 10, and plenty report it dying by hour 6 or 7. That spread is normal, and it comes down to how fast your body clears the drug, not whether you’re taking it right. The 14-hour figure everyone quotes comes from one workplace study, and it measures something different from what you feel at 3 PM.

If you’ve ever stared at the clock at 2 in the afternoon wondering why your supposedly 12-hour med checked out early, you’re in good company. The gap between the number on the label and the number your brain reports is one of the most common frustrations ADHDers have with Vyvanse. It’s also one of the most misunderstood, because the label range and your Tuesday are answering two different questions.

“Everyone swears Vyvanse is a 12-hour med and mine is dead by 2 PM. I take it at 6, feel it around 8, and by early afternoon it’s like I never took anything. Am I broken or is the 12 hours just a lie?”

You’re not broken. This piece covers where that number comes from, what the med feels like across a real day, and which levers change your personal duration.

Where the 10 to 14 hours number comes from

The Vyvanse prescribing information lists a duration of effect up to about 14 hours in adults.^[1] That 14-hour figure traces back largely to a single adult study run in a simulated workplace environment. Dose-optimized adults taking 30, 50, or 70mg beat placebo on a timed math-performance test at every measured interval, from 2 hours after dosing through 14 hours, with statistically strong results at each point.^[2]

The 14-hour mark wasn’t where the drug stopped working. It was the last time point the researchers chose to measure. The study was built to check math-test performance at set intervals during a workday, and 14 hours after the morning dose happened to be the edge of that window. If they’d measured at 16 hours, we might all be quoting a different number.

The result is also a group average. It tells you that, across a room full of dose-optimized adults, average measurable performance on a math test stayed above placebo out to the last check. It doesn’t promise that any single person in that room would say they still felt medicated at hour 14. Average test performance and the subjective sense of “I can focus” are related, but they aren’t the same thing, and they don’t fade at the same time.

The 10-to-14-hour range is real data, accurately reported. It just answers “how long does average measurable performance stay elevated in a group” rather than “how long will you personally feel it.” Those are different questions, and the second one is the one you care about at 3 PM.

Why Vyvanse feels smoother: the prodrug mechanism

Vyvanse works differently from most stimulants because when you swallow it, it isn’t active yet. Lisdexamfetamine is a prodrug: a molecule of d-amphetamine chemically bonded to the amino acid lysine. In that bonded form it doesn’t do anything in your brain.^[3]

Your body has to cut that bond before the active drug is released. This happens through enzymatic hydrolysis, mostly in red blood cells, which cleave the lysine off and free the d-amphetamine into your bloodstream.^[3],[4] That conversion step is rate-limited and saturable, meaning your body can only process so much at a time regardless of how big the dose is. The effect is a built-in, gradual release. Instead of a fast flood of amphetamine, you get a slower, lower, later, and flatter rise than you’d see from an immediate-release amphetamine.^[4]

The lysine cleavage controls the rise, not the fall. It shapes your Onset, smoothing out how the drug ramps up. Once the d-amphetamine is free and circulating, how long it lingers is governed by ordinary elimination, the same clearance machinery that handles any amphetamine. The prodrug design gives you a gentler on-ramp; the length of the tail is decided separately.

What Vyvanse feels like across the day

Because the conversion is gradual, Vyvanse tends to come up slowly. Many people don’t feel much for the first 45 to 90 minutes while their red blood cells are still converting the prodrug.^[1],[4] Then the Active window builds toward a peak effect somewhere around 3.5 to 4 hours in, followed by a long, gentle taper through the Wearing Off phase.

Compared with immediate-release amphetamine, which spikes hard and drops off with a noticeable edge, Vyvanse’s curve is flatter and rounder. That’s the mechanical reason so many people describe it as “smoother.” If you want a deeper look at how curve shape drives the felt experience, our Adderall IR vs XR deep dive breaks down the difference between a sharp spike and a rolling hill.

A rough phase timeline for a morning dose, in approximate hours. Your own numbers will shift based on the levers in the next section.

Time after dose	Phase	What it tends to feel like
0 to 1 hr	Onset	Little to nothing yet; RBCs still converting the prodrug
1 to 2.5 hr	Onset building	Focus coming online, ramping up gradually
3.5 to 4 hr	Active (peak effect)	Strongest coverage; clearest focus
4 to 8 hr	Active, gentle taper	Steady but slowly easing
8 to 12+ hr	Wearing Off	Effect fading; timing varies widely by person

The key thing that timeline hides is how much the right-hand side moves. Two people can take the same 50mg at the same time and land in completely different places by hour 8.

What changes YOUR Vyvanse duration

If your experience doesn’t match the label, one of these four levers is usually responsible.

1. Genetic clearance speed. This is the biggest factor by a wide margin. How quickly your body eliminates d-amphetamine is largely built in, and it varies enormously between people. The same dose can clear noticeably faster or slower from one person to the next.^[4] A fast clearer and a slow clearer taking the same milligrams can have durations that differ by hours. Neither is doing anything wrong; their kidneys and enzymes just run at different speeds.

2. Urine pH. This one is controllable, and it’s the mechanism behind the “orange juice kills my meds” reports. Amphetamine is a weak base, so its excretion depends on how acidic or alkaline your urine is. Acidic urine, driven by vitamin C, ascorbic acid, citrus, and high-acid diets, traps amphetamine in a form your kidneys flush out faster, which shortens the effect. Alkaline urine, from things like baking soda or some antacids, promotes reabsorption back into the bloodstream and can extend the half-life by roughly 2 to 3 hours, a real pharmacological effect that explains the orange-juice reports.^[5]

“Figured out my meds were dying early because I was slamming an orange juice with breakfast every day. Switched to water and got maybe two extra hours. Nobody at my clinic mentioned this.”

3. Food timing. Eating, especially a high-fat meal, delays the active-drug peak by about an hour but doesn’t reduce total absorption.^[1] A big fatty breakfast can push your Onset later and shift your whole curve, without changing how much drug you ultimately get. That can feel like a slower start even though the dose is unchanged.

4. Body weight, dose, hydration, and organ function. Larger bodies, hydration levels, and kidney and liver function all nudge clearance in one direction or another. For reference, children tend to clear the active drug about 1 to 2 hours faster than adults, which is one reason pediatric and adult experiences differ.^[1]

Each of these has a different fix, which is why it helps to know which lever is in play rather than assuming the problem is your own effort.

Your Vyvanse curve is your own. Get Zesty! builds your phase timeline around how fast you clear the drug, so you can see your own Onset, Active, and Wearing Off windows instead of guessing against a study average. Log a few days and the pattern that’s been invisible starts to show up on a graph.

Wearing off early and rebound are not the same problem

These two get lumped together constantly, and telling them apart changes what you do about it.

Wearing off early means the drug has cleared your system sooner than you’d like. The medication level has dropped low enough that you’re no longer covered. This is a duration-and-timing question, tied to your clearance speed, your urine pH, and your dose.^[6]

Rebound is different. Rebound, sometimes called the crash, is what some people feel when the medication level drops too quickly, producing a stretch of irritability, fog, fatigue, or emotional rawness as the drug clears.^[7] The issue there is the rate of the drop, not the total length of coverage. You can have solid all-day duration and still hit a rough rebound at the tail; you can also wear off early without any rebound at all.

The distinction matters because people experiencing rebound often assume they need more medication and ask for a dose increase. A bigger dose usually means more amphetamine to clear, which can bring more side effects while the drop stays just as steep. The pattern of rebound points toward the shape of the curve rather than a need for more milligrams. In practice, some clinicians approach a fast tail with a small short-acting booster to soften the descent rather than raising the long-acting dose, though what fits your situation is a conversation with your prescriber, not something to try on your own.^[6],[7]

The practical move is telling the two apart: whether the med has run out, or is leaving in a way that feels bad.

If Vyvanse isn’t lasting: switching and equivalence context

If Vyvanse clears fast for you no matter what you try, that pattern is worth acting on. It may point toward a different long-acting formulation or a timing conversation with your prescriber.

For rough orientation, about 30mg of Vyvanse is often considered comparable to roughly 10mg of active amphetamine content in Adderall XR.^[6] Treat that as a mental map for orientation only; the actual conversion is your prescriber’s call, and individual response varies. The “smoother” reputation Vyvanse carries is a real mechanical property of the prodrug design, though smoother and longer aren’t the same thing.

“Coming off Adderall XR and my doctor said Vyvanse would be smoother. It is, no jagged peak, no wall at hour 4, but it also doesn’t last as long for me as they promised. Smoother, shorter.”

That trade-off is common. A flatter curve can feel better hour to hour while still ending sooner than a spikier one, depending on your metabolism. If Vyvanse’s shape suits you but the length doesn’t, there are other long-acting options with different release profiles worth discussing. Our cheat sheet on all 14 FDA-approved ADHD medications and their timing lays out how the alternatives compare so you can walk into that appointment with specifics.

None of this means your Vyvanse is failing or that you’re taking it wrong. It means the label describes a population, and you’re a person with your own clearance speed, your own diet, and your own body. The 10-to-14-hour range was never a promise made to you individually; it was an average measured to the edge of a study window. Once you know that, “why does mine wear off at hour 7” becomes a trackable question about your own chemistry, and your clearance speed becomes a variable you can watch instead of a discipline problem. Track your real windows across a few days, tell wearing off from rebound, and bring that specific pattern to the person who prescribes for you. Those are the numbers worth planning your day around.

References

1. ¹ FDA, "Vyvanse (lisdexamfetamine dimesylate) Prescribing Information" — U.S. Food and Drug Administration, 2023
2. ² "Vyvanse provided significant efficacy at 14 hours in adults with ADHD in a simulated workplace environment" — Shire / EurekAlert
3. ³ Ermer JC, Pennick M, Frick G, "Lisdexamfetamine Dimesylate: Prodrug Delivery, Amphetamine Exposure and Duration of Efficacy" — Clinical Drug Investigation (PMC4823324)
4. ⁴ Dolder PC et al., "Pharmacokinetics and Pharmacodynamics of Lisdexamfetamine Compared with D-Amphetamine in Healthy Subjects" — Frontiers in Pharmacology (PMC5594082)
5. ⁵ "Mechanistic PBPK Modeling of Urine pH Effect on Renal and Systemic Disposition of Methamphetamine and Amphetamine" — Journal of Pharmacology and Experimental Therapeutics (PMC7250368)
6. ⁶ "Short-Acting vs. Long-Acting Stimulants: Comparing ADHD Medications" — ADDitude Magazine
7. ⁷ "Peaks and Troughs: Uneven Medication Coverage" — CHADD, Attention Magazine